Distribution of lymphocyte and CD4⁺ T cell in each patient group.

<p>PBMC from each patient group were stimulated for 4h ex vivo with PMA and ionomycin in the presence of Golgi Stop. The percentage of target cells was measured by flowcytometry. <b>(A)</b> The representative figure of flowcytometric analysis for lymphocyte and CD4⁺ T cell. <b>(B)</b> The proportion (%) of Lymphocyte/Total cells and <b>(C)</b> CD4⁺ T/Lymphocyte cells in each group. * <i>P</i><0.05 for each comparison. LTS, long term stable; CAD, chronic allograft dysfunction; ES, early stable; ESRD, end stage renal disease; HC, healthy control.